We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+2.1%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.23B
AUM Growth
-$381M
(-15%)
Cap. Flow
-$365M
Cap. Flow
% of AUM
-16.4%
Top 10 Holdings %
Top 10 Hldgs %
38.36%
Holding
222
New
46
Increased
40
Reduced
47
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola Europacific Partners
CCEP
|
+$35.5M |
| 2 |
AGN
Allergan Inc
AGN
|
+$33M |
| 3 |
Brinker International
EAT
|
+$26.9M |
| 4 |
CBRE Group
CBRE
|
+$26.7M |
| 5 |
JKS
JinkoSolar
JKS
|
+$26.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$58.6M |
| 2 |
Home Depot
HD
|
+$46.7M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$31.7M |
| 4 |
NFX
Newfield Exploration
NFX
|
+$23.5M |
| 5 |
Range Resources
RRC
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.39% |
| 2 | Technology | 9.23% |
| 3 | Consumer Staples | 7.82% |
| 4 | Energy | 5.85% |
| 5 | Consumer Discretionary | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
CALL
Vanda Pharmaceuticals
VNDA
$321M
| $3.11M | 0.14% |
300,000
-100,000
| -25% | -$1.31M |
|
127
Eledon Pharmaceuticals
ELDN
$269M
| $3.1M | 0.14% |
+1,265
| New | +$3.6M |
|
128
Signet Jewelers
SIG
$3.78B
| $2.89M | 0.13% |
25,390
+390
| +2% | +$43.1K |
|
129
Monster Beverage
MNST
$92.1B
| $2.66M | 0.12% |
174,000
-36,000
| -17% | -$472K |
|
130
Applied Optoelectronics
AAOI
$10.6B
| $2.63M | 0.12% |
163,204
-191,696
| -54% | -$3.8M |
|
|
PNK
131
DELISTED
Pinnacle Entertainment Inc.
PNK
| $2.59M | 0.12% |
79,247
-90,753
| -53% | -$2.23M |
|
|
TVPT
132
DELISTED
Travelport Worldwide Limited
TVPT
| $2.47M | 0.11% |
+150,000
| New | +$2.45M |
|
133
State Street SPDR S&P Homebuilders ETF
XHB
$1.54B
| $2.22M | 0.1% |
75,000
-425,000
| -85% | -$13.2M |
|
|
MEG
134
DELISTED
Media General, Inc
MEG
| $2.16M | 0.1% |
165,000
-635,823
| -79% | -$11.4M |
|
135
Element Solutions
ESI
$9.48B
| $2.16M | 0.1% |
86,373
-834,000
| -91% | -$22M |
|
|
ATRS
136
DELISTED
Antares Pharma, Inc.
ATRS
| $2.13M | 0.1% |
1,165,738
| – | – |
|
|
ABMD
137
DELISTED
Abiomed Inc
ABMD
| $2.08M | 0.09% |
83,900
| – | – |
|
|
LIN
138
DELISTED
LIN MEDIA LLC CLASS A COM
LIN
| $1.89M | 0.08% |
85,000
-365,000
| -81% | -$9.07M |
|
139
Acadia Healthcare
ACHC
$2.95B
| $1.7M | 0.08% |
35,000
| – | – |
|
|
DVAX
140
DELISTED
Dynavax Technologies
DVAX
| $1.49M | 0.07% |
104,438
| – | – |
|
|
ICPT
141
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.42M | 0.06% |
+6,000
| New | +$1.53M |
|
|
ADNC
142
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
| $1.19M | 0.05% |
161,000
-21,089
| -12% | -$193K |
|
|
TLOG
143
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
| $1.17M | 0.05% |
286,801
| – | – |
|
144
MediWound
MDWD
$184M
| $751K | 0.03% |
17,143
| – | – |
|
145
Macy's
M
$6.89B
| $689K | 0.03% |
11,846
-213,154
| -95% | -$12.6M |
|
146
American Airlines Group
AAL
$11B
| $653K | 0.03% |
450,000
-19,709
| -4% | -$775K |
|
147
Cerus
CERS
$441M
| $501K | 0.02% |
+125,000
| New | +$481K |
|
148
Akamai
AKAM
$17.9B
| – | – |
-270,000
| Closed | -$16.5M |
|
149
Aramark
ARMK
$14.8B
| – | – |
-173,125
| Closed | -$3.23M |
|
150
Bath & Body Works
BBWI
$4.24B
| – | – |
-262,244
| Closed | -$12.4M |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Kingdon Capital Management held 222 positions worth $2.23B, down 15% from $2.61B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Kingdon Capital Management withdrew a net $365M in Q3 2014, closing 69 positions and reducing 47 holdings. Its most notable exit was Halliburton, an estimated $58.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Kingdon Capital Management opened a new position in Allergan Inc worth $35.4M.
- Kingdon Capital Management's largest Q3 2014 buy was Allergan Inc: 198,700 shares worth $35.4M.
- Kingdon Capital Management added most to Coca-Cola Europacific Partners in Q3 2014, an estimated $35.5M increase.
- Kingdon Capital Management's biggest Q3 2014 reduction was Home Depot, cutting an estimated $46.7M.
- Kingdon Capital Management fully exited Halliburton in Q3 2014, selling an estimated $58.6M.
- Kingdon Capital Management's ten largest holdings make up 38% of its $2.23B portfolio in Q3 2014.
- Kingdon Capital Management opened 46 new positions and closed 69 in Q3 2014.
- Kingdon Capital Management's portfolio value fell 15% quarter-over-quarter to $2.23B.
Based on Kingdon Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.